Cargando…
Combination Therapy Using Inhalable GapmeR and Recombinant ACE2 for COVID-19
Here we report our perspective on applying GapmeR technology in combination with recombinant angiotensin-converting enzyme 2 (ACE2) in the treatment of COVID-19 patients. GapmeR is a cell-permeating antisense single-stranded DNA molecule that can be designed to specifically target intracellular seve...
Autores principales: | Verma, Navin Kumar, Fazil, Mobashar Hussain Urf Turabe, Duggan, Shane P., Kelleher, Dermot |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427089/ https://www.ncbi.nlm.nih.gov/pubmed/32850978 http://dx.doi.org/10.3389/fmolb.2020.00197 |
Ejemplares similares
-
GapmeR cellular internalization by macropinocytosis induces sequence-specific gene silencing in human primary T-cells
por: Fazil, Mobashar Hussain Urf Turabe, et al.
Publicado: (2016) -
Effects of hsa-piR-32877 Suppression with Antisense LNA GapmeRs on the Proliferation and Apoptosis of Human Acute Myeloid Leukemia Cells
por: Nasseri, Sepideh, et al.
Publicado: (2023) -
GSK3β Interacts With CRMP2 and Notch1 and Controls T-Cell Motility
por: Fazil, Mobashar Hussain Urf Turabe, et al.
Publicado: (2021) -
The steroidal lactone withaferin A impedes T-cell motility by inhibiting the kinase ZAP70 and subsequent kinome signaling
por: Fazil, Mobashar Hussain Urf Turabe, et al.
Publicado: (2021) -
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity
por: Amodio, Nicola, et al.
Publicado: (2018)